IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,047,225 | -54.4% | 230,154 | -29.5% | 0.00% | -66.7% |
| Q2 2023 | $2,297,386 | +152.5% | 326,333 | +119.2% | 0.00% | +200.0% |
| Q1 2023 | $909,734 | +3.2% | 148,893 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $881,356 | +309.9% | 137,925 | +1479.0% | 0.00% | – |
| Q3 2021 | $215,000 | -4.0% | 8,735 | +1.6% | 0.00% | – |
| Q2 2021 | $224,000 | -74.1% | 8,600 | -68.5% | 0.00% | -100.0% |
| Q1 2021 | $864,000 | -42.2% | 27,302 | -15.3% | 0.00% | -66.7% |
| Q4 2020 | $1,495,000 | +45.1% | 32,218 | +3.0% | 0.00% | +50.0% |
| Q3 2020 | $1,030,000 | +24.1% | 31,277 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $830,000 | -14.3% | 30,227 | -6.7% | 0.00% | -33.3% |
| Q1 2020 | $969,000 | -11.1% | 32,410 | -17.7% | 0.00% | +50.0% |
| Q4 2019 | $1,090,000 | – | 39,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |